The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-World stocks ring in new year with record highs

Mon, 04th Jan 2021 09:09

* MSCI All-Country World Index hits record high

* Bitcoin trades above $32,000

* Yuan surges nearly 1% vs. dollar

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Ritvik Carvalho

LONDON, Jan 4 (Reuters) - World stock markets hit record
highs on Monday, the first trading day of the new year, as
investors hoped the rollout of vaccines would ultimately lift a
global economy decimated by the COVID-19 pandemic.

The Chinese yuan surged nearly 1% against the dollar,
while the greenback plumbed its lowest levels against a basket
of peer currencies since April 2018. Bitcoin took a 10%
dive, falling below $30,000 after a blistering 800% rally since
mid-March last year.

By 1126 GMT, European stock indexes were all higher, with
Britain's FTSE 100 gaining 2.76%, Germany's DAX up 1.3%
, Spain's IBEX up 1.36% and Italy's FTSE MIB
rising 1%. The pan-European STOXX 600 index was on
course for its best day since Nov. 9, up 1.6%.

E-Mini futures for the S&P 500 were up 0.6%, after
also touching a record high.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, hit a record high and was up 0.6% on
the day.

"The year kicks off as 2020 ended, an everything rally with
the double V dichotomy (virus vs. vaccine) seeing the hopes that
either things get worse and stimulus ramps up or things get
better and, well, things get better so long as there’s no hint
of liquidity withdrawal and a taper tantrum," a trader said.

Asian stock markets also gained, although Japan's Nikkei 225
index shed early gains, falling 0.4% after Prime
Minister Yoshihide Suga confirmed the government was considering
a state of emergency for Tokyo and three surrounding prefectures
as the coronavirus spreads.

Despite the optimism over vaccines, investors are still
sounding caution over the path of the virus, which continues to
spread amidst the discovery of a new strain.

"The virus retains the upper hand for a while longer," said
Karl Steiner, chief quantitative strategist at SEB, noting that
vaccinations have had an uneven start, characterized by vaccine
shortages, vaccine resistance and delays.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

"We continue to believe that equities have further room to
rise in 2021 as monetary and fiscal stimulus measures provide a
tailwind, and we anticipate significant earnings growth as the
global economy recovers," said Mark Haefele, chief investment
officer at UBS Global Wealth Management.

Minutes of the Federal Reserve's December meeting are due on
Wednesday and should offer more detail on discussions about
making their forward policy guidance more explicit and the
chance of a further increase in asset buying this year.

EYES ON DATA

The data calendar includes a raft of manufacturing surveys
across the globe, which will show how industry is coping with
the spread of the coronavirus, and the closely watched ISM
surveys of U.S. factories and services.

Chinese factory activity continued to accelerate in
December, though the PMI missed forecasts.

Japanese manufacturing stabilised for the first time in two
years in December, while Taiwan picked up.

Friday sees the U.S. December payroll report where median
forecasts are for only a modest increase of 100,000 jobs.

Analysts as Barclays are tipping a fall of 50,000 in jobs,
which would be a shock to market hopes of a speedy recovery.

"A number of incoming indicators on activity point to slower
momentum as the economy closes out the year, including data on
labour markets where initial claims rose during the December
survey period," said economist Michael Gapen in a note.

Such a drop would add pressure on the Fed to ease further,
another burden for the dollar which is already buckling under
the weight of the massive U.S. budget and trade deficits.

In currencies, the euro pushed back up to $1.2294,
having run into profit-taking late last week when it reached the
highest since early 2018 at $1.2309. It gained almost 9% over
2020.

The dollar slipped to 102.80 yen. Sterling firmed to
$1.3690, levels last seen in mid-2018.

The decline in the dollar has been a support for gold,
leaving the metal 1.3% firmer at $1,931 an ounce.

Oil prices extended their rise after a couple of months of
solid gains, with Brent crossing $53 a barrel.
U.S. crude added 1% to $49 a barrel.

(Reporting by Ritvik Carvalho; additional reporting by Carolyn
Cohn in London and Wayne Cole in Sydney; Editing by Toby Chopra)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.